CAROLINE CLAAR: Open Payments
NPI 1942673322 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,785 in 126 payments from 28 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $2,785
Food & beverage: $2,785
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 40 | $604 |
| Lundbeck LLC | 12 | $288 |
| Eisai Inc. | 7 | $262 |
| UCB, Inc. | 10 | $235 |
| Novartis Pharmaceuticals Corporation | 9 | $226 |
| Axsome Therapeutics, Inc. | 6 | $163 |
| Otsuka America Pharmaceutical, Inc. | 5 | $125 |
| Biogen, Inc. | 5 | $121 |
| Teva Pharmaceuticals USA, Inc. | 5 | $113 |
| Neurocrine BioSciences, Inc. | 3 | $93 |
Products named: QULIPTA, Leqembi, VYEPTI, KESIMPTA, Symbravo, BOTOX, REXULTI, INGREZZA.
Industry payments across GA — which companies pay providers there.
